Three of the Best Deals on the Street: FUQI, JMBA, EXEL
Fuqi International (FUQI) Gains on Return of China’s Middle Class Consumers; Jamba (JMBA) Signs Deal to Expand in Las Vegas; Exelixis (EXEL) Makes a Strong Comeback Quarter.
2 Comment(s)
 |
SmallCap Network Stock Research
|
|
| Small Cap Stock Analysis |
Three Stocks Positioned for Big Moves: NVMI, CENTA, SVA
Nova Measuring (NVMI) Raises Full-Year Guidance; Central Garden & Pet Company (CENTA) Turns in a Solid Q3; Sinovac Biotech (SVA) Gains on Q2 Anticipation.
The Big Bang Theory: JADE, CELM, ZGEN
LJ International (JADE) Wholesale/Retail Segments Strong in Q2; China Electric Motor (CELM) Bounces Back in a Big Way; ZymoGenetics (ZGEN) Turnaround is Remarkable.
Hate What They Love, Love What They Hate - MBI, USB, & SKX are Anti-Trades
Small cap stocks U.S. Bancorp (NYSE:USB), MBIA Inc. (NYSE:MBI), and Skechers USA, Inc. (NYSE:SKX) are a little too loved or too hated by the crowd.
Two Undervalued Stocks and a Threshold Play: CONN, SRSL, TNDM
Conns (CONN) Posts a Mixed Quarter; SRS Labs (SRSL) Posts Y-O-Y Rev Increase of 42%; Neutral Tandem (TNDM) Generates Solid Earnings for Shareholders.
When Opportunity Knocks; Answer the Door: PPCO, WATG, IMMU
Penwest Pharmaceuticals (PPCO) Delvers a Record Quarter; Wonder Auto Technology (WATG) Gains on Q2 Anticipation; Immunomedics (IMMU) Undervalued; Simple as that.
Widen Your Focal Point & Get the Real Story - Looks at TSN, OMEX, and DISH
Small caps DISH Network Corp. (NASDAQ:DISH), Tyson Foods, Inc. (NYSE:TSN), and Odyssey Marine Exploration, Inc. (NASDAQ:OMEX) are reviewed for trading potential.
Are These Ready to Lead the Charge: CCIX, ORBC, XTXI
Coleman Cable (CCIX) Posts a Strong Q2 in Manufacturing Sector; ORBCOMM (ORBC) Gives Q2 Numbers Today; Crosstex Energy (XTXI) Q2 Revenues Rise 15%.
Three Stocks Set to Breakout: TTHI, WSTL, MHLD
Transition Therapeutics (TTHI) Deep Pipeline is Undervalued; Westell Technologies (WSTL) Posts 133% Y-O-Y Revenue Gain; Maiden Holdings (MHLD) Declares a Cash Dividend.
The Shape of Things to Come: CRME, DIVX, CSUN
Cardiome Pharma (CRME) Waiting on the European Commission; DivX (DIVX) Revenues Grow Y-O-Y; China Sunergy (CSUN) Q2 Posts Diluted EPS of +$0.33.
